Prudential Financial Inc Intercept Pharmaceuticals, Inc. Transaction History

Prudential Financial Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$12.53 - $21.71 $2.82 Million - $4.89 Million	225,376 New	225,376 $3.03 Million
Q4 2019 Feb 11, 2020	BUY	$57.36 - $124.1 $332,630 - $719,655	5,799 Added 218.01%	8,459 $1.05 Million
Q2 2019 Aug 08, 2019	BUY	$77.77 - $120.68 $206,712 - $320,767	2,658 Added 132900.0%	2,660 $0
Q1 2019 Aug 05, 2021	SELL	$91.83 - $120.68 $213,780 - $280,943	-2,328 Reduced 99.91%	2 $0
Q1 2019 May 15, 2019	BUY	$91.83 - $120.68 $3,673 - $4,827	40 Added 1.75%	2,330 $0
Q4 2018 Feb 07, 2019	SELL	$85.79 - $126.46 $2,573 - $3,793	-30 Reduced 1.29%	2,290 $230,000
Q3 2018 Nov 07, 2018	BUY	$88.49 - $127.55 $205,296 - $295,916	2,320 New	2,320 $0

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.